Nontropical Pyomyositis: Analysis of Eight Patients in an Urban Center

Hossain, Azhar; Reis, Ernane D.; Soundararajan, Krish; Kerstein, Morris D.; Hollier, Larry H.
November 2000
American Surgeon;Nov2000, Vol. 66 Issue 11, p1064
Academic Journal
Nontropical pyomyositis is rare and usually associated with immunodeficiency virus (HIV) infection. This study assessed manifestations and response to treatment of nontropical pyomyositis in an area with a high prevalence of HIV seropositivity. We undertook a chart review of eight consecutive patients treated for pyomyositis--primary infection of skeletal muscles--from 1988 through 1998. All patients complained of myalgia; four (50%) had fever and six (75%) had leukocytosis. Muscles involved were deltoid, quadriceps, gluteus, and psoas. Six (75%) patients had identifiable risk factors for pyomyositis: HIV seropositivity (two), history of intravenous drug abuse (one), chronic paraplegia and malnutrition (one), diabetes and chronic renal failure (one), and leukemia (one). One patient had had streptococcal pharyngitis previously but was otherwise healthy; another, a 2-year-old, had no evidence of underlying disease. Staphylococcus aureus was the most common organism isolated (50%). Four patients were treated with incision and drainage plus antibiotics; the remaining four patients were treated with intravenous antibiotics only; all recovered. Nontropical pyomyositis, which is often associated with HIV seropositivity or chronic illness, has a favorable outcome. Treatment can be effective even without surgical intervention.


Related Articles

  • ABC of AIDS: Treatment of infections. Weller, Ian V D; Williams, I G // BMJ: British Medical Journal (International Edition);06/02/2001, Vol. 322 Issue 7298, p1350 

    Presents information on the treatment of patients infected with the AIDS virus. Risk associated with Pneumocystis carinii pneumonia in those patients who fail to take adequate prophylaxis or in those who are newly diagnosed with advanced disease; Commonality of cerebral toxoplasmosis; Details...

  • Highly Active Antiretroviral Therapy and Incidence of Cancer in Human Immunodeficiency...  // JNCI: Journal of the National Cancer Institute;11/15/2000, Vol. 92 Issue 22, p1823 

    Compares the incidence of Kaposi's sarcoma, non-Hodgkin's lymphoma, Hodgkin's disease, cervical cancer and other cancers in HIV-infected people for the years before and after the highly active antiretroviral therapy (HAART) came into widespread use. Follow-up data from perspective studies that...

  • THALIDOMIDE FOR TREATMENT OF ORAL APHTHOUS ULCERS IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS: CASE REPORT AND REVIEW. Ball, Susan C.; Sepkowitz, Kent A.; Jacobs, Jonathan L. // American Journal of Gastroenterology;Jan1997, Vol. 92 Issue 1, p169 

    Presents a case report of the result of thalidomide use for the treatment of aphtous ulcers in patients with HIV. Medical history; Historical background on the use thalidomide; Overview of reports of HIV-infected patients who had received thalidomide.

  • Long-Term Metabolic Consequences of Switching from Protease Inhibitors to Efavirenz in Therapy for Human Immunodeficiency Virus—Infected Patients with Lipoatrophy. Estrada, V.; de Villar, N. G. P.; Martinez Larrad, M. L.; Gonzalez Lopez, A.; Fernandez, C.; Serrano-Rios, M. // Clinical Infectious Diseases;7/1/2002, Vol. 35 Issue 1, p69 

    The roles of nucleoside analogues and protease inhibitors (PIs) in the development of metabolic complications and fat-distribution abnormalities associated with highly active antiretroviral therapy (HAART) are not well known. We performed an observational study in which efavirenz was substituted...

  • Temporal Trends in Presentation and Survival for HIV-Associated Lymphoma in the Antiretroviral Therapy Era. Gopal, Satish; Patel, Monita R.; Yanik, Elizabeth L.; Cole, Stephen R.; Achenbach, Chad J.; Napravnik, Sonia; Burkholder, Greer A.; Reid, Erin G.; Rodriguez, Benigno; Deeks, Steven G.; Mayer, Kenneth H.; Moore, Richard D.; Kitahata, Mari M.; Eron, Joseph J.; Richards, Kristy L. // JNCI: Journal of the National Cancer Institute;8/21/2013, Vol. 105 Issue 16, p1221 

    Background Lymphoma is the leading cause of cancer-related death among HIV-infected patients in the antiretroviral therapy (ART) era. Methods We studied lymphoma patients in the Centers for AIDS Research Network of Integrated Clinical Systems from 1996 until 2010. We examined differences...

  • Oral thalidomide benefits Kaposi's.  // Dermatology Times;Sep2000, Vol. 21 Issue 9, p43 

    Reports on the clinical trial of thalidomide which found it to be safe and effective in the treatment of Kaposi's sarcoma in a subset of HIV-infected patients. Research undertaken by Robert Yarchoan and colleagues at the National Institutes of Health in Bethesda, Maryland.

  • Angiogenesis inhibitor looks promising in treatment of Kaposi's sarcoma. Roehr, Bob // Dermatology Times;Sep2000, Vol. 21 Issue 9, p45 

    Reports on a phase I trial which found an angiogenesis inhibitor promising in the treatment of Kaposi's sarcoma in patients with HIV. Presentation of data at the 4th International AIDS Malignancy Conference; Compound, Col-3 (Metastat), under patent by CollaGenex Pharmaceuticals; Side effects;...

  • Peculiarities of genital ulcer diseases in HIV-infected patients: Report of four cases from Zaria, Nigeria. Ogoina, Dimie; Muktar, Haruna M.; Obiako, Reginald O. // Annals of African Medicine;2011, Vol. 10 Issue 2, p192 

    The article presents a case study of four case studies of genital ulcer diseases (GUDs) among the HIV-infected patients in northern Nigeria. The cases are in line with the other studies suggesting that GUDs in HIV-infected patients were aggressive, chronic, recurrent, and sometimes related with...

  • Fulminant Shigellosis in a HIV Patient. Ooi, Siang Mei Sally // Case Reports in Infectious Diseases;3/4/2015, Vol. 2015, p1 

    Infectious enterocolitis caused by shigella is usually self-limiting and seldom requires antibiotics treatment. It is uncommon to develop fulminant shigellosis requiring surgery. We report a rare case of fulminant shigellosis in a HIV patient with recurring infection which could not be managed...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics